#346889
An Buanchoiste um Tháirgí Íocshláinte Tréidliachta
Standing Committee on Veterinary Medicinal Products
An Buanchoiste um Tháirgí Íocshláinte Tréidliachta
Standing Committee on Veterinary Medicinal Products
Tabharfaidh an Buanchoiste um Tháirgí Íocshláinte Tréidliachta cúnamh don Choimisiún.
The Commission shall be assisted by the Standing Committee on Veterinary Medicinal Products.
Buanchoiste um Tháirgí Íocshláinte Tréidliachta
Standing Committee on Veterinary Medicinal Products
Déanfaidh an Buanchoiste um Tháirgí Íocshláinte Tréidliachta (“an Buanchoiste”) cúnamh a thabhairt don Choimisiún.
The Commission shall be assisted by the Standing Committee on Veterinary Medicinal Products (‘the Standing Committee’).
Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta dá dtagraítear in Airteagal 145 de Rialachán (AE) 2019/6,
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products referred to in Article 145 of Regulation (EU) 2019/6,
Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir le tuairim an Bhuanchoiste um Táirgí Íocshláinte Tréidliachta,
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,
Na bearta dá bhforáiltear sa Rialachán seo, tá siad i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta,
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,
Is i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta dá dtagraítear in Airteagal 145 de Rialachán (AE) 2019/6 atá na bearta dá bhforáiltear sa Rialachán seo,
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products referred to in Article 145 of Regulation (EU) 2019/6,
Is i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta dá dtagraítear in Airteagal 145 de Rialachán (AE) 2019/6 atá na bearta dá bhforáiltear sa Rialachán seo,
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products referred to in Article 145 of Regulation (EU) 2019/6,
Na bearta dá bhforáiltear sa Chinneadh seo, tá siad i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta,
The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,
Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta,
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,
Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta dá dtagraítear in Airteagal 145 de Rialachán (AE) 2019/6,
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products referred to in Article 145 of Regulation (EU) 2019/6,
Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta,
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,
Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta dá dtagraítear in Airteagal 145 de Rialachán (AE) 2019/6,
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products referred to in Article 145 of Regulation (EU) 2019/6,
Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta,
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,
Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Táirgí Íocshláinte Tréidliachta,
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,
Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Táirgí Íocshláinte Tréidliachta,
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,
Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta,
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,
Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta,
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,
Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta,
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,
Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta,
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,
Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta,
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,
Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir leis an tuairim ón mBuanchoiste um Tháirgí Íocshláinte Tréidliachta,
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,
Tá na bearta dá bhforáiltear sa Rialachán seo i gcomhréir le tuairim an Bhuanchoiste um Plandaí, Ainmhithe, Bia agus Beatha, an Bhuanchoiste um Tháirgí Íocshláinte Tréidliachta agus an Bhuanchoiste ar Zóiteicnic,
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed, the Standing Committee on Veterinary Medicinal Products and the Standing Committee on Zootechnics,
I gcomhréir le tuairimí tromlaigh ó na Ballstáit arna gcur in iúl ag cruinniú an Bhuanchoiste um Tháirgí Íocshláinte Tréidliachta an 2 Nollaig 2019, agus le comhairliúchán spriocdhírithe le geallsealbhóirí tríd an ríomhphost an 26 Samhain 2019, ba cheart an lógó coiteann a mhúnlú ar an lógó coibhéiseach le haghaidh táirgí íocshláinte lena n-úsáid ag an duine.
In accordance with the majority opinions of the Member States expressed at the Standing Committee on Veterinary Medicinal Products’ meeting of 2 December 2019, and a targeted consultation of stakeholders by email on 26 November 2019, the common logo should be modelled on the equivalent logo for medicinal products for human use.